Idiopathic Pulmonary Fibrosis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for idiopathic pulmonary fibrosis. 10 active patents protecting 1 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

1
Approved drugs
10
Active US patents
65/100
Avg vulnerability
—
Annual revenue covered

Originators in Idiopathic Pulmonary Fibrosis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Boehringer Ingelheim 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating idiopathic pulmonary fibrosis. Each bar = one year. Y-axis scaled to peak year (4 patents).

2
29
2
32
2
34
4
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Jascayd
NERANDOMILAST
 Boehringer Ingelheim 10 65 — 2029-11-26

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8754073 Jascayd method of use 81 2029-11-26
8754073 Jascayd method of use 81 2029-11-26
9802954 Jascayd method of use 75 2034-02-19
9802954 Jascayd method of use 75 2034-02-19
11813266 Jascayd method of use 75 2038-10-22
11406638 Jascayd method of use 75 2038-10-22
11406638 Jascayd method of use 75 2038-10-22
11813266 Jascayd method of use 75 2038-10-22
8609670 Jascayd composition of matter 17 2032-08-23
8609670 Jascayd composition of matter 17 2032-08-23

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8609670 Jascayd composition of matter 17 2032-08-23
8609670 Jascayd composition of matter 17 2032-08-23
11406638 Jascayd method of use 75 2038-10-22
11813266 Jascayd method of use 75 2038-10-22
11813266 Jascayd method of use 75 2038-10-22
11406638 Jascayd method of use 75 2038-10-22
9802954 Jascayd method of use 75 2034-02-19
9802954 Jascayd method of use 75 2034-02-19
8754073 Jascayd method of use 81 2029-11-26
8754073 Jascayd method of use 81 2029-11-26

Related